Corbus Pharmaceuticals Holdings IncNASDAQ:CRBP
- LAST PRICE45.2000
- TODAY'S CHANGE (%)-3.3500 (-6.9001%)
- Bid / Lots43.5000/ 2
- Ask / Lots46.0000/ 2
- Open / Previous Close48.3000 / 48.5500
- Day Range
- 52 Week Range
- Volume341,903
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRBP |
|---|---|---|
| 09:32 ET | 1067 | 48.55 |
| 09:34 ET | 1683 | 48.415 |
| 09:38 ET | 100 | 48.83 |
| 09:39 ET | 100 | 48.83 |
| 09:41 ET | 2300 | 48.615 |
| 09:43 ET | 100 | 48.98 |
| 09:45 ET | 796 | 49.31 |
| 09:48 ET | 2059 | 49.545 |
| 09:50 ET | 300 | 49.5087 |
| 09:52 ET | 300 | 49.565 |
| 09:54 ET | 1000 | 49.525 |
| 09:56 ET | 22304 | 50.23 |
| 09:57 ET | 5240 | 49.82 |
| 09:59 ET | 1614 | 49.82 |
| 10:01 ET | 8769 | 49.82 |
| 10:03 ET | 100 | 49.74 |
| 10:06 ET | 500 | 49.825 |
| 10:08 ET | 200 | 49.82 |
| 10:10 ET | 200 | 49.6675 |
| 10:12 ET | 1800 | 50 |
| 10:14 ET | 3578 | 49.96 |
| 10:15 ET | 1283 | 50.145 |
| 10:17 ET | 1900 | 49.62 |
| 10:19 ET | 409 | 49.8764 |
| 10:21 ET | 5155 | 49.11 |
| 10:28 ET | 3100 | 48.3 |
| 10:30 ET | 1906 | 48.31 |
| 10:33 ET | 100 | 49.48 |
| 10:35 ET | 8118 | 48.33 |
| 10:37 ET | 5426 | 48.0756 |
| 10:39 ET | 1239 | 47.72 |
| 10:42 ET | 229 | 47.73 |
| 10:44 ET | 1400 | 47.65 |
| 10:48 ET | 1053 | 47.1 |
| 10:50 ET | 1216 | 47.2724 |
| 10:51 ET | 250 | 47.065 |
| 10:53 ET | 400 | 47.065 |
| 10:55 ET | 600 | 47.07 |
| 10:57 ET | 200 | 47.3449 |
| 11:02 ET | 600 | 47.0101 |
| 11:04 ET | 200 | 47.62 |
| 11:08 ET | 300 | 47.7279 |
| 11:09 ET | 100 | 47.66 |
| 11:11 ET | 100 | 47.545 |
| 11:13 ET | 323 | 47.555 |
| 11:22 ET | 100 | 47.56 |
| 11:27 ET | 100 | 47.66 |
| 11:29 ET | 100 | 47.745 |
| 11:31 ET | 2500 | 47.65 |
| 11:33 ET | 1097 | 47.37 |
| 11:38 ET | 7796 | 46.27 |
| 11:40 ET | 325 | 46.25 |
| 11:42 ET | 860 | 46.2 |
| 11:44 ET | 300 | 46.01 |
| 11:45 ET | 950 | 46.225 |
| 11:47 ET | 300 | 46.04 |
| 11:49 ET | 1154 | 46.47 |
| 11:51 ET | 100 | 46.22 |
| 11:54 ET | 717 | 46.19 |
| 11:56 ET | 200 | 46.15 |
| 11:58 ET | 100 | 46.3943 |
| 12:00 ET | 150 | 46.3622 |
| 12:02 ET | 100 | 46.55 |
| 12:03 ET | 100 | 46.705 |
| 12:05 ET | 100 | 46.55 |
| 12:07 ET | 300 | 46.54 |
| 12:14 ET | 2706 | 46.03 |
| 12:18 ET | 100 | 46.145 |
| 12:20 ET | 100 | 46.42 |
| 12:23 ET | 500 | 46.06 |
| 12:25 ET | 400 | 46.08 |
| 12:27 ET | 200 | 46.105 |
| 12:32 ET | 4119 | 45.5 |
| 12:34 ET | 2231 | 45.8 |
| 12:36 ET | 250 | 45.8515 |
| 12:48 ET | 1925 | 45.9 |
| 12:52 ET | 100 | 46.16 |
| 12:54 ET | 390 | 46.05 |
| 12:56 ET | 700 | 46.03 |
| 12:59 ET | 154 | 45.975 |
| 01:01 ET | 300 | 45.795 |
| 01:06 ET | 200 | 46.2599 |
| 01:08 ET | 400 | 45.76 |
| 01:10 ET | 108 | 45.975 |
| 01:12 ET | 100 | 46.08 |
| 01:15 ET | 300 | 45.75 |
| 01:17 ET | 286 | 45.94 |
| 01:21 ET | 100 | 45.85 |
| 01:24 ET | 317 | 45.78 |
| 01:26 ET | 26952 | 45.38 |
| 01:28 ET | 6816 | 45.43 |
| 01:30 ET | 600 | 45.22 |
| 01:33 ET | 3898 | 45.39 |
| 01:35 ET | 200 | 45.47 |
| 01:39 ET | 1800 | 45.395 |
| 01:42 ET | 100 | 45.55 |
| 01:44 ET | 750 | 45.55 |
| 01:46 ET | 4907 | 45.555 |
| 01:48 ET | 7689 | 45.21 |
| 01:50 ET | 200 | 45.385 |
| 01:51 ET | 2616 | 46.11 |
| 01:53 ET | 500 | 46.13 |
| 01:55 ET | 2200 | 46.07 |
| 01:57 ET | 3049 | 46.14 |
| 02:00 ET | 100 | 45.98 |
| 02:02 ET | 300 | 45.725 |
| 02:06 ET | 200 | 45.98 |
| 02:08 ET | 800 | 46.14 |
| 02:09 ET | 583 | 46.59 |
| 02:13 ET | 900 | 46.21 |
| 02:18 ET | 1647 | 46.86 |
| 02:20 ET | 575 | 47.19 |
| 02:22 ET | 380 | 47.1425 |
| 02:24 ET | 999 | 46.79 |
| 02:26 ET | 100 | 46.84 |
| 02:33 ET | 1000 | 47.15 |
| 02:44 ET | 200 | 46.52 |
| 02:45 ET | 500 | 46.525 |
| 02:49 ET | 100 | 46.5734 |
| 02:54 ET | 517 | 46.5825 |
| 03:00 ET | 400 | 46.3 |
| 03:03 ET | 200 | 46.25 |
| 03:05 ET | 500 | 46.2 |
| 03:09 ET | 100 | 46.295 |
| 03:12 ET | 200 | 46.2706 |
| 03:14 ET | 100 | 46.215 |
| 03:16 ET | 100 | 46.08 |
| 03:18 ET | 200 | 46.27 |
| 03:20 ET | 327 | 45.7145 |
| 03:21 ET | 149 | 45.75 |
| 03:23 ET | 200 | 45.745 |
| 03:27 ET | 950 | 46.45 |
| 03:30 ET | 215 | 46.0385 |
| 03:32 ET | 300 | 45.83 |
| 03:34 ET | 315 | 46.09 |
| 03:36 ET | 200 | 46.09 |
| 03:39 ET | 11907 | 46.125 |
| 03:41 ET | 4872 | 45.615 |
| 03:43 ET | 2103 | 45.65 |
| 03:45 ET | 666 | 45.6 |
| 03:48 ET | 3730 | 45.305 |
| 03:50 ET | 2032 | 45.3 |
| 03:52 ET | 4791 | 45.22 |
| 03:54 ET | 6913 | 45.275 |
| 03:56 ET | 10914 | 45.3201 |
| 03:57 ET | 5112 | 45.25 |
| 03:59 ET | 5752 | 45.2 |
May 13, 2024
DJ Corbus Pharmaceuticals Initiated at Outperform by RBC Capital, from 7:34AM ET on Monday May 13, 2024 by Dow Jones
7:34AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference, from 8:00AM ET on Thursday May 09, 2024 by Dow Jones
8:00AM ET on Thursday May 09, 2024 by Dow Jones
May 8, 2024
DJ Corbus Pharmaceuticals Currently Up Nine Consecutive Days, on Track for Record Winning Streak -- Data Talk, from 2:52PM ET on Wednesday May 08, 2024 by Dow Jones
2:52PM ET on Wednesday May 08, 2024 by Dow JonesDJ Corbus Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 12:04PM ET on Wednesday May 08, 2024 by Dow Jones
12:04PM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 8:01AM ET on Tuesday May 07, 2024 by Dow Jones
8:01AM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 518.8M | -6.5x | --- |
Celcuity Inc | 524.7M | -5.9x | --- |
Astria Therapeutics Inc | 526.6M | -4.0x | --- |
Korro Bio Inc | 506.3M | -1.2x | --- |
Olema Pharmaceuticals Inc | 532.5M | -4.6x | --- |
Erasca Inc | 533.1M | -2.8x | --- |
Company Information
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Contact Information
- Headquarters
- 500 River Ridge DriveNORWOOD, MA, United States 02062
- Phone
- 617-963-0103
- Fax
- ---
Executives
- Independent Director
- Alan Holmer
- Chief Executive Officer, Director
- Yuval Cohen
- Chief Financial Officer
- Sean Moran
- Chief Medical Officer
- Dominic Smethurst
- Independent Director
- Anne Altmeyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $518.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.56 |
EPS | $-6.97 |
Book Value | $-1.56 |
P/E Ratio | -6.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
